Nephrogenic systemic fibrosis (NSF) is a progressive disorder that occurs only in those with chronic kidney disease or impaired kidney function. It is associated with gadolinium-based contrasting agents used for Magnetic Resonance Imaging (MRI) or Magnetic Resonance Angiogram (MRA).
NSF usually develops two to 18 months after the MRI. The first symptoms are elevated blood pressure, mild headaches, nausea, and dizziness as well as itching, burning and swelling in the arms and legs. As symptoms progress, the skin starts to harden and turn shiny. It may have red patches. NSF can spread to the arms, chest, and abdomen. It may affect internal organs. Victims develop raised, yellow spots on their eyes. When NSF affects the lungs, it can cause breathing problems. The damage is irreversible.
Every known case of NSF has occurred after and MRI or MRA with a gadolinium-based dye. The Wisconsin drug injury attorneys at Hupy and Abraham are helping NSF patients find accountability and justice through gadolinium injury lawsuits. These suits are being filed against the makers of the five gadolinium-based contrasting agents approved for use in the United States:
- Bayer Healthcare, the maker of Magnevist (gadopentetate dimeglumine)
- Bracco, the manufacturer of MultiHance (gadobenate dimeglumine) and ProHance (gadoteridol)
- GE Healthcare, the maker of Omniscan (gadodiamide)
- Mallinckrodt, the maker of OptiMARK (gadoversetamide)
These lawsuits allege that the drug companies failed to properly research potential side-effects of their product and neglected to warn doctors and the public about potential risks. Our Milwaukee pharmaceutical injury lawyers file nephrogenic systemic fibrosis lawsuits to help those diagnosed with NSF to receive compensation for medical expenses, lost wages, and general pain and suffering.
We know that a lawsuit can’t stop NSF, but the compensation from a suit can help ease the financial burden associated with the condition. To learn more, please call the Milwaukee NSF attorneys at Hupy and Abraham at 800-800-5678.